BMF Blocking Peptide

Antibody Target

BMF
Accession

NP_001030110.1
Gene ID

362100
Appearance

Colorless liquid
Concentration

0.5 mg/ml
Formulation

50 µg (0.5 mg/ml) in phosphate buffered saline (PBS), pH 7.2, containing 50% glycerol, 1% BSA and 0.02% thimerosal.
Application Usage

The peptide is used for blocking the antibody activity of BMF (Cat.# 3334R-100). It usually blocks the antibody activity completely in Western blot analysis by incubating the peptide with equal volume of antibody for 30-60 minutes at 37°C.
Storage Temp

-20 °C
Shipping

gel pack
Shelf Life

12 months
Western Blot WB

Verified
Handling

The peptide solution should be gently mixed before use.
DataSheet Link
Research Use

For Rersearch Use Only! Not to be used in humans.
Test

You can block the antibody by the specific target amino acid sequence of peptide.
Properties

blocking peptide
Description

Peptides short amino acid chains or epitopes or blocking antagonists. The shortest peptides are dipeptides, consisting of 2 amino acids joined by a single peptide bond, followed by tripeptides, tetra peptides, ... till polypeptides that are long, continuous, and unbranched synthetic peptide chains. These biological oligomers and polymers can be Solid-phase peptide synthesis (SPPS), or in continue produced for custom peptide synthesis projects. The High-efficiency solid phase peptide synthesis (HE-SPPS) is give very low production costs.

Gene target

BMF
Gene symbol

BMF, BMF-AS1
Short name

BMF Blocking Peptide
Technique

blocking peptide, Blocking, peptide, blocking peptides, Biovision made this blocking amino acid sequence or peptide to block the gene target in a volume of 1. For western blot it is often requested to block your antibody and to see the band of the analyzed protein disappear. This is called a negative control by blocking the WB antibody. peptides
Alternative name

Bcl2 modifying factor inhibiting short protein sequence
Alternative technique

control, peptides
Alternative to gene target

Bcl2 modifying factor, BMF and IDBG-6070 and ENSG00000104081 and 90427, protein binding, Plasma membranes, Bmf and IDBG-198160 and ENSMUSG00000040093 and 171543, BMF and IDBG-646206 and ENSBTAG00000012180 and 541141